Sotagliflozin considerably reduces coronary heart assaults and strokes in high-risk sufferers with diabetes and kidney illness, providing a brand new remedy choice for cardiovascular safety. Sotagliflozin, a lately FDA-approved drug for treating kind 2 diabetes and kidney illness in sufferers with further cardiovascular threat elements, has been proven to considerably scale back the danger of coronary heart assault and […]
Source link
An extended-term research suggests {that a} particular blood biomarker might reveal the earliest organic shifts linked to Alzheimer’s illness, even earlier than standard mind imaging detects them. Credit...
Read more










